HERE+NOW.IMPULSE MAGAZINE // Special Edition 2019
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
EW Biotech scales<br />
biotechnological<br />
processes in Leuna<br />
The chemical park in Leuna is a small<br />
world of its own. No one is allowed to<br />
drive on the premises without an identity card<br />
check and safety instructions. Inside, the traditional<br />
industrial area is linked together by a<br />
kilometre-long network of roads, rails, pipelines<br />
and power cables. More than 6,000 people<br />
work at the 1,300 hectare site – Leuna has<br />
made a name for itself in the chemical industry.<br />
One of the many companies based at the<br />
chemical park is EW Biotech GmbH. It is here<br />
that the leap from the laboratory to the<br />
industrial production is rehearsed. An American<br />
company, for instance, commissioned EW<br />
Biotech with the production of small quantities<br />
of 1.3-butylene glycol, which is used as a moisturiser<br />
in a variety of creams. “At our facility,<br />
we are able to scale any biotechnological<br />
process and bring it to industrial maturity. Our<br />
customers commission us with producing the<br />
initial tonnes of a substance. Only two or three<br />
companies in the world are able to do this. That<br />
makes us into a sought-after partner,” explains<br />
Managing Director Dr. Joachim Schulze, while<br />
representatives from an American start-up sit<br />
in the next room and negotiate future projects<br />
with the developers from Leuna. In addition to<br />
scaling and contract manufacturing, the EW<br />
Biotech facility also facilitates research and<br />
12